Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone.
Strotmann
Jörg M
JM
Medical University Clinic, Würzburg, Germany. J.Strotnmann@medizin.uni-wuerzburg.de
Spindler
Matthias
M
Weilbach
Franz X
FX
Gold
Ralf
R
Ertl
Georg
G
Voelker
Wolfram
W
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D016022:Case-Control Studies; D003402:Creatine Kinase / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D016037:Single-Blind Method; D013318:Stroke Volume / Q000187:drug effects
D000970:Antineoplastic Agents; D008942:Mitoxantrone; D003402:Creatine Kinase